3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
Fluorouracil
12
Radiotherapy
8
Cisplatin
8
pembrolizumab
4
Papillomavirus Vaccines
4
Mitomycin
4
Irinotecan
4
Cyclophosphamide
4
Cetuximab
4
Light Coagulation
3
Interleukin-12 Subunit p35
3
Capecitabine
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Trastuzumab
2
Surveys and Questionnaires
2
Radiation
2
Quality of Life
2
Paclitaxel
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
Early Intervention, Educational
2
Carboplatin
2
Biopsy
2
toripalimab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anus Neoplasms
×
Therapeutics
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled